AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TRINITRINE

10 registrations across 3 African markets— 9 active

Markets with TRINITRINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NATISPRAY
Solution pour pulvérisation buccale / 0.3 mg/dose
🇹🇳TunisiaTEOFARMA S.R.LexpiredApr 2010
NATISPRAY
solution / 0,30 mg / dose
🇸🇳SenegalTEOFARMAactive
NITRODERM TTS 5
DISPOSITIF TRANSDERMIQUE
🇲🇦Moroccoactive
NITROGLICERINE PH&T 25MG/5ML
SOLUTION INJECTABLE POUR PERFUSION
🇲🇦Moroccoactive
NATISPRAY
SOLUTION POUR PULVERISATION BUCCALE
🇲🇦Moroccoactive
NATISPRAY
solution / 0,30 mg / dose
🇸🇳SenegalTEOFARMAactive
NITROGLICERINE PH&T 5 MG/ML
SOLUTION INJECTABLE POUR PERFUSION
🇲🇦Moroccoactive
NITROGLICERINE PH&T 5 MG/ML
SOLUTION INJECTABLE POUR PERFUSION
🇲🇦Moroccoactive
NITRODERM TTS 10
DISPOSITIF TRANSDERMIQUE
🇲🇦Moroccoactive
NITROGLICERINE PH&T 25MG/5ML
SOLUTION INJECTABLE POUR PERFUSION
🇲🇦Moroccoactive

TRINITRINE in Africa — Regulatory Overview

TRINITRINE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.